Literature DB >> 31095259

Real-world Evidence-What Does It Really Mean?

Chadi Nabhan1, Andrew Klink2, Vinay Prasad3.   

Abstract

Mesh：

Year:  2019        PMID： 31095259     DOI： 10.1001/jamaoncol.2019.0450

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  14 in total

1.  Practical Application of Real-World Evidence in Developing Cancer Therapies.

Authors:  Marjorie G Zauderer
Journal:  JCO Clin Cancer Inform       Date:  2019-07

2.  Ranking evidence in substance use and addiction.

Authors:  Hudson Reddon; Thomas Kerr; M-J Milloy
Journal:  Int J Drug Policy       Date:  2020-07-06

Review 3.  Impact of Real-World Data on Market Authorization, Reimbursement Decision & Price Negotiation.

Authors:  Alfredo Aram Pulini; Gabriela Martins Caetano; Henri Clautiaux; Laure Vergeron; Peter J Pitts; Gregory Katz
Journal:  Ther Innov Regul Sci       Date:  2020-08-28       Impact factor: 1.778

4.  Outcomes after a Digital Behavior Change Intervention to Improve Trauma Triage: An Analysis of Medicare Claims.

Authors:  Deepika Mohan; Chung-Chou Chang; Baruch Fischhoff; Matthew R Rosengart; Derek C Angus; Donald M Yealy; Amber E Barnato
Journal:  J Surg Res       Date:  2021-08-28       Impact factor: 2.192

Review 5.  Harnessing big data to characterize immune-related adverse events.

Authors:  Ying Jing; Jingwen Yang; Douglas B Johnson; Javid J Moslehi; Leng Han
Journal:  Nat Rev Clin Oncol       Date:  2022-01-17       Impact factor: 65.011

6.  Nivolumab in pre-treated advanced non-small cell lung cancer: long term follow up data from the Dutch expanded access program and routine clinical care.

Authors:  Robert D Schouten; Lucie Egberink; Mirte Muller; Cornedine J De Gooijer; Erik van Werkhoven; Michel M van den Heuvel; Paul Baas
Journal:  Transl Lung Cancer Res       Date:  2020-10

7.  Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study.

Authors:  Kun Zhang; Xiya Ma; Hongjun Gao; Hong Wang; Haifeng Qin; Shaoxing Yang; Xiaoqing Liu
Journal:  Cancer Manag Res       Date:  2020-05-13       Impact factor: 3.989

8.  Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy.

Authors:  Ying Jing; Xue Chen; Kunyan Li; Yaoming Liu; Zhao Zhang; Yiqing Chen; Yuan Liu; Yushu Wang; Steven H Lin; Lixia Diao; Jing Wang; Yanyan Lou; Douglas B Johnson; Xiang Chen; Hong Liu; Leng Han
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

9.  An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients.

Authors:  Simon Erridge; Oliver Salazar; Michal Kawka; Carl Holvey; Ross Coomber; Azfer Usmani; Mohammed Sajad; Sushil Beri; Jonathan Hoare; Shaheen Khan; Mark W Weatherall; Michael Platt; James J Rucker; Mikael H Sodergren
Journal:  Neuropsychopharmacol Rep       Date:  2021-05-14

10.  The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer.

Authors:  Fen Wang; Feng Jin; Boran Cheng; Yue Zhang; Qing Zhou; Shubin Wang
Journal:  J Cancer Res Clin Oncol       Date:  2021-08-06       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.